Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis

Abstract excerpt

The identification of small molecules that target specific CFTR variants has ushered in a new era of treatment for cystic fibrosis (CF), yet optimal, individualized treatment of CF will require identification and targeting of disease modifiers. Here we use genome-wide association analysis to identify genetic modifiers of CF lung disease, the primary cause of mortality. Meta-analysis of 6,365 CF patients...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cystic Fibrosis Research Advances
• Share to Epigenetics and DNA Methylation
• Share to Neonatal Respiratory Health Research